Stockreport

Sellas Life Sciences: REGAL Study Results Due Any Day Are A Major Potential Upside Catalyst [Seeking Alpha]

SELLAS Life Sciences Group, Inc.  (SLS) 
Last sellas life sciences group, inc. earnings: 11/14 04:41 pm Check Earnings Report
PDF Extended overall survival in the REGAL trial is interpreted as a strong signal of GPS efficacy, positioning SLS for potential FDA priority review and blockbuster status [Read more]